sun pharma's cs muralidharan on q4 results, taro acquisition plans & fy24 outlook | halftime report
Published 1 year ago • 605 plays • Length 10:07Download video MP4
Download video MP3
Similar videos
-
1:02
wholesale prices rose 0.2% in august, in line with expectations
-
6:49
sun pharma's buyout plans & q4 numbers | cs muralidharan explains | business news
-
8:53
sun pharma's c s muralidharan speaks on the firm's q2fy23 results & fy23 revenue guidance
-
4:33
sun pharma margins trend to sustain in coming quarters? | cs muralidharan explains | et now
-
10:50
⚡️ centerra gold inc. (cgau) - تجزیه و تحلیل شرکت cgau درجه guru.markets 📈
-
3:47
big returns will come from small-caps while fed cuts rates, says goldman's ashish shah
-
2:24
powers: the fed is going to gradually cut rates, guiding the economy into a soft landing
-
5:19
jd vance on tariffs and taxes
-
1:13
sun pharma's subsidiary taro pharma reports good q3 earnings with margin at 10.8% | cnbc tv18
-
5:34
arvind's punit lalbhai on q4 results, fy24 & fy25 outlook | halftime report | cnbc-tv18
-
9:31
sun pharma's q3 net profit rises 5% yoy: c.s. muralidharan tracks the firm's q3fy23 earnings
-
6:50
biocon's kiran mazumdar shaw on strong q4, biosimilar business & fy24 outlook | halftime report
-
2:26
here are key expectations from sun pharma's q3fy23 earnings | halftime report | cnbc-tv18
-
8:19
us biosecure act provides a big opportunity to indian pharma industry: biocon & biocon biologics
-
5:36
keshav bhajanka talks about century ply's q2fy23 results | halftime report | cnbc-tv18
-
2:26
market expert ashish kyal's cues for trade & market outlook for today | halftime report | cnbc-tv18
-
1:29
sun pharma attempts to acquire taro fully after 10 years | business news | et now
-
2:16
sun pharma's halol facility receives u.s. fda warning letter | business lunch | cnbc-tv18
-
1:23
#earningsminute: sun pharma misses street estimates this q4
-
8:26
axis capital's prakash agarwal decodes outlook for pharma & healthcare sector | halftime report
-
1:51
why are speciality chemical stocks in focus? | cnbc tv18
-
2:36
u.s. fda issues warning letter to sun pharma, questions manufacturing practices at halol facility